Experimental studies in atherosclerosis-prone animals have consistently shown that genetic deletion or pharmacological inhibition of IL-1 signaling reduces the formation and progression of atherosclerotic plaques5,7. The gene discussed is IL1B; the disease is atherosclerosis.